Fall is here, which means respiratory viruses like flu, RSV and COVID are expected to keep spreading as weather cools and more people gather indoors. Luckily, we've got vaccines in stock to help ...

Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring ... standalone influenza shot developed by Novavax Inc (NASDAQ:NVAX).

Respiratory syncytial virus (RSV) is a leading cause ... levels and to elicit a Th1 immune response. Novavax is testing a postfusion F protein vaccine formulated with alum in both older adults ...

All folks age 75 and up are recommended for an RSV vaccine ... Moderna, Pfizer or Novavax. For more on this year's COVID vaccines, read about how Novavax compares to the two mRNA shots.

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

2 strain, prompting the approval of updated versions of the Pfizer and Moderna vaccines targeting that particular strain, and the Novavax vaccine ... for the flu and RSV. For people interested ...

A lot of older adults also need protection against another risky winter virus, RSV. Yes, you can get your flu and COVID ...

Previously, the adjuvanted RSV prefusion F protein-based vaccine had been approved only for adults ages 60 and older. Then in October, the FDA expanded the approval of Pfizer's bivalent RSV ...

A lot of older adults also need protection against another risky winter virus, RSV. Yes, you can get your ... 2 while the Novavax vaccine targets its parent strain, JN.1. Daskalakis said all ...